GleamWall
中文EN

MMSI MERIT MEDICAL SYSTEMS INC

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 856982 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY9.1%
TTM net income YoY35.2%
TTM EPS YoY36.9%
Revenue 3-yr CAGR9.5%
Net income 3-yr CAGR16.9%

Margins

Gross margin49.4%
Operating margin13.5%
Net margin9.9%
FCF margin12.6%
EBITDA margin21.3%

Returns

ROE9.8%
ROA5.8%
ROIC (approx.)8.5%
Asset turnover0.58x

Leverage & solvency

Liabilities / assets40.4%
Debt / equity0.42x
Current ratio4.52x
Interest coverage6.73x

Cash quality & payout

Operating cash flow / net income1.71x
Accruals ratio-4.1%
Payout ratio—
Capex / revenue4.4%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$416.24M$418.84M$381.88M$393.94M$384.16M$382.46M$355.35M$355.16M
Cost of revenue$215.61M$203.68M$197.08M$198.58M$197.75M$197.97M$183.33M$182.18M
Gross profit$200.63M$215.17M$184.80M$195.35M$186.41M$184.49M$172.02M$172.98M
R&D expense$22.39M$25.39M$22.61M$26.54M$23.97M$24.37M$22.48M$25.19M
SG&A expense$119.51M$129.23M$118.21M$114.83M$119.80M$113.10M$107.49M$111.07M
Operating income$58.76M$60.40M$44.16M$54.20M$42.61M$46.88M$41.03M$36.56M
Interest expense$7.33M$12.12M$6.53M$6.36M$6.75M$6.78M$6.57M$7.99M
Pretax income$55.78M$51.31M$53.55M$51.06M$38.54M$43.38M$37.96M$33.15M
Income tax$13.47M$12.51M$12.55M$13.05M$10.79M$10.80M$7.81M$5.20M
Net income$42.31M$38.80M$40.99M$38.01M$27.75M$32.58M$30.15M$27.95M
EBITDA$90.66M$91.40M$74.65M$85.73M$73.91M$77.88M$70.33M$65.18M
EPS (basic)0.710.650.69—0.470.550.51—
EPS (diluted)0.700.650.68—0.460.540.49—
Weighted avg. shares (diluted)60.38M60.01M60.01M—59.92M60.61M61.28M—
Balance sheet
Cash & equivalents$503.55M$448.70M$488.08M$446.40M$392.46M$341.82M$395.53M$378.77M
Receivables$221.87M$224.24M$206.45M$203.71M$210.29M$204.16M$199.55M$190.24M
Inventory$391.02M$374.11M$352.39M$333.70M$326.55M$323.31M$317.94M$306.06M
Current assets$1.20B$1.11B$1.10B$1.04B$985.53M$923.07M$958.63M$923.77M
PP&E, net$437.35M$436.75M$433.96M$428.40M$418.00M$409.99M$390.32M$386.17M
Goodwill$537.13M$539.77M$503.43M$506.84M$507.43M$504.56M$464.36M$463.51M
Total assets$2.92B$2.86B$2.72B$2.69B$2.63B$2.59B$2.47B$2.42B
Current liabilities$265.08M$264.93M$216.87M$239.76M$230.47M$225.57M$196.82M$216.40M
Long-term debt$737.40M$736.26M$735.16M$734.04M$732.92M$731.79M$730.67M$729.55M
Total debt$737.40M$736.26M$735.16M$734.04M$732.92M$731.79M$730.67M$729.55M
Total liabilities$1.18B$1.18B$1.09B$1.10B$1.10B$1.10B$1.04B$1.04B
Shareholders' equity$1.74B$1.68B$1.63B$1.58B$1.53B$1.49B$1.43B$1.38B
Net debt$233.85M$287.56M$247.08M$287.63M$340.46M$389.98M$335.14M$350.78M
Shares outstanding59.90M59.71M59.66M59.42M59.29M59.22M59.08M58.74M
Cash flow statement
Operating cash flow$65.27M$69.28M$40.68M$98.51M$74.98M$83.31M$40.57M$68.74M
Capital expenditure$12.35M$17.33M$16.01M$24.46M$22.44M$13.75M$21.06M$3.47M
Free cash flow$52.93M$51.95M$24.67M$74.05M$52.54M$69.56M$19.51M$65.27M
Investing cash flow-$22.32M-$110.13M$7.73M-$50.34M-$24.07M-$143.35M-$29.64M-$214.45M
Financing cash flow$11.61M$948,000-$6.29M$5.06M-$365,000$4.35M$6.96M$2.43M
Depreciation & amortization$31.90M$31.00M$30.50M$31.54M$31.30M$31.00M$29.29M$28.62M
Stock-based compensation$13.62M$12.91M$8.96M$9.90M$13.61M$10.87M$9.08M$9.52M

Free plan shows the latest 8 periods; Pro shows all 67 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.